12 12

Cited 0 times in

Litholytic agents as an alternative treatment modality in patients with biliary dyspepsia

 Young Min Kim  ;  Sung Ill Jang  ;  Jae Hee Cho  ;  Dong Hee Koh  ;  Chang-Il Kwon  ;  Tae Hoon Lee  ;  Seok Jeong  ;  Dong Ki Lee 
 MEDICINE, Vol.99(34) : e21698, 2020-08 
Journal Title
Issue Date
Adult ; Bile* ; Chenodeoxycholic Acid / therapeutic use* ; Dyspepsia / drug therapy* ; Dyspepsia / etiology* ; Female ; Gallbladder / physiopathology ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Ursodeoxycholic Acid / therapeutic use*
Biliary dyspepsia presents as biliary colic in the absence of explanatory structural abnormalities. Causes include gallbladder dyskinesia, sphincter of Oddi dysfunction, biliary tract sensitivity, microscopic sludges, and duodenal hypersensitivity. However, no consensus treatment guideline exists for biliary dyspepsia. We investigated the effects of medical treatments on biliary dyspepsia.We retrospectively reviewed the electronic medical records of 414 patients who had biliary pain and underwent cholescintigraphy from 2008 to 2018. We enrolled patients who received litholytic agents and underwent follow-up scans after medical treatment. We divided the patients into the GD group (biliary dyspepsia with reduced gallbladder ejection fraction [GBEF]) and the NGD group (biliary dyspepsia with normal GBEF). We compared pre- and post-treatment GBEF and symptoms.Among 57 patients enrolled, 40 (70.2%) patients had significant GBEF improvement post-treatment, ranging from 34.4 ± 22.6% to 53.8 ± 26.8% (P < .001). In GD group (n = 35), 28 patients had GBEF improvement after medical treatment, and value of GBEF significantly improved from 19.5 ± 11.0 to 47.9 ± 27.3% (P < .001). In NGD group (n = 22), 12 patients had GBEF improvement after medical treatment, but value of GBEF did not have significant change. Most patients (97.1% in GD group and 81.8% in NGD group) had improved symptoms after medical treatment. No severe complication was reported during treatment period.Litholytic agents improved biliary colic in patients with biliary dyspepsia. Therefore, these agents present an alternative treatment modality for biliary dyspepsia with or without gallbladder dyskinesia. Notably, biliary colic in patients with gallbladder dyskinesia resolved after normalization of the GBEF. Further prospective and large-scale mechanistic studies are warranted.
Files in This Item:
T202003391.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Lee, Dong Ki(이동기) ORCID logo https://orcid.org/0000-0002-0048-9112
Jang, Sung Ill(장성일) ORCID logo https://orcid.org/0000-0003-4937-6167
Cho, Jae Hee(조재희)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.